Biomarkers associated with COVID-19 disease progression

G Ponti, M Maccaferri, C Ruini, A Tomasi… - Critical reviews in …, 2020 - Taylor & Francis
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …

Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study

T Bahmer, C Borzikowsky, W Lieb, A Horn, L Krist… - …, 2022 - thelancet.com
Summary Background Post-COVID syndrome (PCS) is an important sequela of COVID-19,
characterised by symptom persistence for> 3 months, post-acute symptom development …

Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis

GV Soraya, ZS Ulhaq - Medicina clinica, 2020 - Elsevier
Introduction and objectives Common laboratory parameters are crucial in aiding coronavirus
disease 2019 (COVID-19) case detection. This study aimed to determine the differences …

Plasma biomarkers for systemic inflammation in COVID‐19 survivors

J Zhao, M Schank, L Wang, X Dang… - PROTEOMICS …, 2022 - Wiley Online Library
Background While the majority of COVID‐19 patients fully recover from the infection and
become asymptomatic, a significant proportion of COVID‐19 survivors experience a broad …

A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)

C Danwang, FT Endomba, JR Nkeck, DLA Wouna… - Biomarker …, 2020 - Springer
Background Prognostic factors for the Coronavirus disease 2019 (COVID1–9) are not well
established. This study aimed to summarize the available data on the association between …

Risk factors of severe cases with COVID-19: a meta-analysis

M Ou, J Zhu, P Ji, H Li, Z Zhong, B Li, J Pang… - Epidemiology & …, 2020 - cambridge.org
Our study aimed to systematically analyse the risk factors of coronavirus disease 2019
(COVID-19) patients with severe disease. An electronic search in eight databases to identify …

Laboratory findings of COVID-19: a systematic review and meta-analysis

ZL Zhang, YL Hou, DT Li, FZ Li - Scandinavian journal of clinical …, 2020 - Taylor & Francis
Abstract The Coronavirus Disease (COVID-19) pandemic first broke out in December 2019
in Wuhan, China, and has now spread worldwide. Laboratory findings have been only …

Deciphering the COVID‐19 cytokine storm: systematic review and meta‐analysis

R Mulchandani, T Lyngdoh… - European journal of …, 2021 - Wiley Online Library
Introduction The coronavirus pandemic has affected more than 20 million people so far.
Elevated cytokines and suppressed immune responses have been hypothesized to set off a …

[HTML][HTML] Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19

LH Willems, M Nagy, H Ten Cate, HMH Spronk… - Thrombosis research, 2022 - Elsevier
Introduction Endothelial damage and thrombosis caused by COVID-19 may imperil
cardiovascular health. More than a year since the WHO declared COVID-19 pandemic …

Early prediction of disease progression in patients with severe COVID‐19 using C‐reactive protein to albumin ratio

Y Li, H Li, C Song, R Lu, Y Zhao, F Lin, D Han… - Disease …, 2021 - Wiley Online Library
Background. Early identification of patients with severe coronavirus disease (COVID‐19) at
an increased risk of progression may promote more individualized treatment schemes and …